6 Jahre Erfahrungen mit einem Arzneimittelberatungsdienst für Patienten

ZusammenfassungHintergrund und Ziel:Viele Patienten sind nur ungenügend über ihre Arzneimitteltherapie informiert. Daher besteht bei ihnen der Bedarf an zusätzlichen Informationen über Arzneimittel. Die Erfahrungen mit einem Arzneimittelberatungsdienst für Patienten werden hier berichtet.Patienten und Methodik:Der Beratungsdienst war über Telefon, E-Mail sowie auf dem Postweg erreichbar und richtete sich zu Beginn an Patienten in Sachsen, seit 2005 an Personen aus ganz Deutschland. Sowohl demographische wie auch arzneimitteltherapiebezogene Daten der Patienten wurden erfasst und mittels einer relationalen Datenbank analysiert. Alle an den Beratungsdienst gerichteten Anfragen zwischen August 2001 und Januar 2007 wurden ausgewertet.Ergebnisse:5 587 Anfragen wurden registriert. 61,4% der anfragenden Personen waren weiblich und 33,8% männlich (Geschlecht unbekannt bei 4,8% aufgrund anonymer Anrufe). Allgemeiner Informationsbedarf zu Arzneimitteln und Therapie (27,5%) und Fragen zu Nebenwirkungen (24,7%) waren die am häufigsten genannten Anfragegründe. Die am meisten nachgefragte Arzneistoffgruppe stellten Arzneimittel für das kardiovaskuläre System mit 34,4% dar, gefolgt von Pharmaka für neuropsychiatrische Erkrankungen mit 15,1%.Schlussfolgerung:Die Ergebnisse dieser Auswertung zeigen einen offensichtlichen Bedarf an einem Arzneimittelberatungsdienst für Patienten. Dieser lässt sich möglicherweise auf Zeitmangel bei den Ärzten zurückführen. Ein unabhängiger und fachkundiger Arzneimittelinformationsdienst vermag die Qualität der medizinischen Versorgung sowie die Zufriedenheit der betroffenen Patienten zu verbessern.AbstractBackground and Purpose:Many patients are inadequately informed about their drug therapy. There is thus a need for providing additional drug information to patients. The authors here report on a 6-year experience with a drug information service for patients.Patients and Methods:The information service was available by telephone, e-mail or regular mail and was addressed initially to patients in Saxony and since 2005 to patients throughout Germany. Demographic and drug therapy data of the patients were registered and analyzed using a relational database. All enquiries to the information service between August 2001 and January 2007 were evaluated.Results:5,587 enquiries were registered. 61.4% of the persons calling were female and 33.8% male (sex was unknown in 4.8% by anonymous calls). The most frequent reasons for an enquiry were a general need for information about drugs and therapy (27.5%) and adverse drug reactions (24.7%). The drug group most frequently enquired about were cardiovascular drugs, accounting for 34.4%, followed by neuropsychiatric drugs (15.1%).Conclusion:The results of this analysis show an evident need for a drug information service for patients. This need is possibly caused by the shortage of time that physicians can devote to patients. An independent and competent drug information service may improve the quality of medical care and the satisfaction of the patients involved.

[1]  M. Höfler,et al.  Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS) , 2004, Psychological Medicine.

[2]  M. Siepmann,et al.  Regional drug information service. , 1999, International journal of clinical pharmacology and therapeutics.

[3]  G. Bailie,et al.  Who provides patients with drug information? , 1987, British medical journal.

[4]  M. Berkovitch,et al.  Consumption of herbal remedies and dietary supplements amongst patients hospitalized in medical wards. , 2007, British journal of clinical pharmacology.

[5]  W. Kirch,et al.  Arzneimittelberatungsdienste als Instrumente der Versorgungsforschung , 2005, Medizinische Klinik.

[6]  J. Avorn,et al.  The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. , 1997, American journal of hypertension.

[7]  J. Wasson,et al.  Telephone care as a substitute for routine clinic follow-up. , 1992, JAMA.

[8]  Jason J Y Woo.  Adverse event monitoring and multivitamin-multimineral dietary supplements. , 2007, The American journal of clinical nutrition.

[9]  Jan De Maeseneer,et al.  Consultation length in general practice: cross sectional study in six European countries , 2002, BMJ : British Medical Journal.

[10]  G. Eysenbach,et al.  The Impact of CyberHealthcare on the Physician–Patient Relationship , 2003, Journal of Medical Systems.

[11]  E. Bartlett,et al.  Cost-benefit analysis of patient education. , 1995, Patient education and counseling.

[12]  Sophie Gautier,et al.  The cost of adverse drug reactions , 2003, Expert opinion on pharmacotherapy.

[13]  P J Schneider,et al.  Cost of medication-related problems at a university hospital. , 1995, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[14]  U. Shaikh,et al.  Electronic Communication With Patients for Breastfeeding Support , 2007, Journal of human lactation : official journal of International Lactation Consultant Association.

[15]  R. Grymonpre,et al.  The Medication Information Line for the Elderly: An 8-Year Cumulative Analysis , 1998, The Annals of pharmacotherapy.

[16]  O. Benkert,et al.  KOMPENDIUM DER PSYCHIATRISCHEN PHARMAKOTHERAPIE , 1998 .

[17]  Peter Bramlage,et al.  High prevalence and poor control of hypertension in primary care: cross-sectional study , 2004, Journal of hypertension.

[18]  Rowan Frost,et al.  Brief Report: Development of a prescription medication information webliography for consumers , 2007, Journal of General Internal Medicine.

[19]  W. Kirch,et al.  First Patient-Centered Drug Information Service in Germany—A Descriptive Study , 2004, The Annals of pharmacotherapy.

[20]  M. Innes.  Telephone consultations. , 2002, The British journal of general practice : the journal of the Royal College of General Practitioners.

[21]  D W Sturdee,et al.  The importance of patient education in improving compliance. , 2000, Climacteric : the journal of the International Menopause Society.

[22]  National survey of dietary supplement resources at drug information centers. , 2004, Journal of the American Pharmacists Association : JAPhA.

[23]  W. Kirch,et al.  Arzneimittelberatung für Patienten - Bedarfsanalyse, Evaluation und Einfluss auf die Compliance , 2005 .

[24]  W. Kirch,et al.  Drug information services: initial experiences in Dresden , 1998, European Journal of Clinical Pharmacology.

[25]  R M Braude,et al.  “Patient informatics”: creating new partnerships in medical decision making , 1998, Academic medicine : journal of the Association of American Medical Colleges.

[26]  J. Balint,et al.  Regaining the initiative. Forging a new model of the patient-physician relationship. , 1996, JAMA.

[27]  W. Kirch,et al.  Arzneimittelberatungsdienste für Ärzte und Patienten , 2007, Der Internist.

[28]  F. Gerlach,et al.  Sachverständigenrat für die Konzertierte Aktion im Gesundheitswesen , 2001 .

[29]  Joyce A. Mitchell,et al.  Electronic Communication With Patients: Evaluation of Distance Medicine Technology , 1997 .

[30]  Martin Schulz,et al.  German national drug information service: user satisfaction and potential positive patient outcomes , 2007, Pharmacy World & Science.

[31]  P. Bendtsen,et al.  Pharmacological Intervention in Older Patients with Rheumatoid Arthritis , 1995, Drugs & aging.

[32]  P S Melnyk,et al.  Impact of the Dial Access Drug Information Service on Patient Outcome , 2000, The Annals of pharmacotherapy.

[33]  J. Margraf,et al.  Drug Use Patterns in Young German Women and Association with Mental Disorders , 2004, The Annals of pharmacotherapy.

[34]  Sturdee Dw,et al.  The importance of patient education in improving compliance. , 2000 .

[35]  K. Thau,et al.  [Noncompliance: an overview]. , 2001, Deutsche medizinische Wochenschrift.

[36]  M. Gulich,et al.  How important is a package insert for drug therapy in ambulatory care? , 2006, Journal of Public Health.

[37]  C. Tsourounis,et al.  Dietary supplement-related adverse events reported to the California Poison Control System. , 2005, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[38]  H. Poulsen,et al.  Are Patients Reliable When Self‐Reporting Medication Use? Validation of Structured Drug Interviews and Home Visits by Drug Analysis and Prescription Data in Acutely Hospitalized Patients 1 , 2007, Journal of clinical pharmacology.